Modified drug release refers to the strategic alteration of the release kinetics of a pharmaceutical compound within the body, aiming to optimize therapeutic outcomes while minimizing adverse effects. This approach encompasses a variety of techniques and formulations designed to exert control over the timing, rate, and location of drug delivery. One common strategy involves the development of sustained-release formulations, where the drug is released gradually over an extended period, maintaining therapeutic concentrations in the bloodstream and thereby reducing the frequency of dosing. These formulations often employ specialized drug delivery systems such as hydrogels, liposomes, or microspheres, which encapsulate the active ingredient and control its release through diffusion, erosion, or other mechanisms.
Another approach to modified drug release involves targeting specific sites or tissues within the body to enhance efficacy and reduce systemic side effects. This can be achieved through the use of targeted drug delivery systems that exploit physiological or pathological characteristics of the target tissue, such as pH, temperature, or enzymatic activity. By encapsulating the drug within carriers that selectively release their cargo in response to these cues, researchers can achieve site-specific drug delivery, maximizing therapeutic effects while minimizing off-target effects.
In addition to sustained-release and targeted delivery approaches, modified drug release can also involve the use of novel drug delivery routes and technologies. For example, transdermal patches and implants allow for continuous and controlled release of drugs through the skin or implanted devices, offering advantages such as improved patient compliance and reduced dosing frequency. Similarly, advances in nanotechnology have enabled the development of nanoscale drug delivery systems capable of crossing biological barriers and delivering drugs to specific cellular targets, opening up new possibilities for personalized medicine and precision therapeutics.
Title : Synthesis of chitosan composite of metal organic framework for the adsorption of dyes, kinetic and thermodynamic approach
Tooba Saeed, University of Peshawar, Pakistan
Title : Time Domain NMR: A new Paradigm in Process Control for Sodium in Foods and Beverages
Dan Kroll, Iowa State University, United States
Title : Synthesis of Copper (II) Oxide Nanoparticles using Curcumin and Investigation of Molecular Interactions through DFT Analysis
Madhulata Shukla, Veer Kunwar Singh University, India
Title : An overview on the correlation of oxidative stress, chronic inflammation, microbial infections, and diabetes mellitus: Therapeutic potential of natural products
Demissie Shimeli, ASTU, Ethiopia
Title : Nature meets innovation: Green synthesis of nanoparticles using plant extracts and ionic liquids for a sustainable future
Azeez A Barzinjy, Soran University, Iraq
Title : Lewis and bronsted acids effects on the mechanism of the diels alder reaction of dimethylfuran. A DFT Study
Hafida Chemouri, Ecole Superieure En Sciences Appliquees De Tlemcen ESSA-Tlemcen, Algeria